An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to Treat Androgenetic Alopecia

January 2017 in “ Hair therapy & transplantation ”

E.R. Vickers

topical zinc-thymulin androgenetic alopecia minoxidil finasteride vellus hairs intermediate hairs melanogenesis anagen male pattern baldness ZT AGA Rogaine Propecia

TLDR Topical zinc-thymulin is safe and effective for treating male pattern baldness.

The study assessed the safety and efficacy of topical zinc-thymulin (ZT) for treating androgenetic alopecia (AGA) in 18 adults (17 males, 1 female) aged 35-90 years. Over 3,300 treatment days, ZT showed no adverse effects and no drug interactions with concurrent minoxidil or finasteride use. Significant hair growth improvements were observed after 6 months, with increases in vellus (32%) and intermediate (23%) hairs, and melanogenesis in several subjects. The study concluded that ZT is safe and effective for initiating and maintaining anagen in male pattern baldness when used for more than 6 months.

View this study on longdom.org →

Discuss this study in the Community →

Related Research

19 / 19 results

research Hair Regrowth Following Topical HairUp Treatment in Subjects with Alopecia Totalis and Alopecia Universalis: A Retrospective Analysis of Efficacy and Cosmetic Acceptability

January 2016 in “Hair therapy & transplantation”

Hair UpTM effectively and safely promotes hair regrowth, especially in minors.

research A Comparative Study of Treatment Modalities in Female Androgenetic Alopecia

3 citations, January 2016 in “International Journal of Research in Medical Sciences”

Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.

research CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

1 citations, January 2013 in “Hair therapy & transplantation”

The document does not provide information about hair loss treatment.

research An Open Label, Multi-Center Clinical Trial of Topical 5% Minoxidil Solution for the Treatment of Male Androgenetic Alopecia (A Phase IV Study)

2 citations, March 2009 in “Journal of Clinical Dermatology”

research Clinical Trial to Evaluate the Safety and Efficacy of Scalp Med in Treatment of Patients with Androgenetic Alopecia

January 2008 in “Journal of Clinical Dermatology”

Topical Fulvestrant Solution Has No Effect on Male and Postmenopausal Female Androgenetic Alopecia: Results from Two Randomized, Proof-of-Concept Studies

research Topical Fulvestrant Solution Has No Effect on Male and Postmenopausal Female Androgenetic Alopecia: Results from Two Randomized, Proof-of-Concept Studies

6 citations, November 2007 in “British Journal of Dermatology”

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

research Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

56 citations, April 2007 in “Journal der Deutschen Dermatologischen Gesellschaft”

Minoxidil works better for female hair loss than alfatradiol, both safe.

research Effects of Finasteride (1 mg) on Hair Transplant

30 citations, March 2006 in “Dermatologic Surgery”

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men

research A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men

269 citations, August 2002 in “Journal of The American Academy of Dermatology”

5% minoxidil works better for hair growth and density, with minor irritation.

Fluridil, A Rationally Designed Topical Agent For Androgenetic Alopecia: First Clinical Experience

research Androgenetic Alopecia in the Female

82 citations, March 1994 in “Archives of Dermatology”

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women

research Topical Minoxidil in Early Male Pattern Baldness

138 citations, August 1985 in “Journal of The American Academy of Dermatology”

Minoxidil promotes hair growth in male pattern baldness.

An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to Treat Androgenetic Alopecia

Related Community Posts Join

community New Latanoprost-Based Formula Used by Hollywood Celebrities

community Microneedling Only Results?? (No fin/minox)

community Theoretically won't this be better than finasteride? Azelaic acid + zinc

community A meta analysis of 18 popular hair loss treatments. An 2022 guide on efficacy. From finasteride and minoxidil to caffeine shampoo, saw palmetto and biotin. 96 Scientific References included.

community 16, female, losing a ton of hair

community Still shedding like this everyday 9 months straight on fin and min. Should I switch to dut?

Related Research

research Hair Regrowth Following Topical HairUp Treatment in Subjects with Alopecia Totalis and Alopecia Universalis: A Retrospective Analysis of Efficacy and Cosmetic Acceptability

research A Comparative Study of Treatment Modalities in Female Androgenetic Alopecia

research CG210 Enables Finasteride 1mg Users to Further Improve Hair Pattern: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

research An Open Label, Multi-Center Clinical Trial of Topical 5% Minoxidil Solution for the Treatment of Male Androgenetic Alopecia (A Phase IV Study)

research Clinical Trial to Evaluate the Safety and Efficacy of Scalp Med in Treatment of Patients with Androgenetic Alopecia

research Topical Fulvestrant Solution Has No Effect on Male and Postmenopausal Female Androgenetic Alopecia: Results from Two Randomized, Proof-of-Concept Studies

research Comparison of the Efficacy and Safety of Topical Minoxidil and Topical Alfatradiol in the Treatment of Androgenetic Alopecia in Women

research Effects of Finasteride (1 mg) on Hair Transplant

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

research A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men

research Fluridil, A Rationally Designed Topical Agent For Androgenetic Alopecia: First Clinical Experience

research Finasteride in the Treatment of Men with Androgenetic Alopecia

research Effect of Minoxidil on Hair Transplantation in Androgenetic Alopecia

research Androgenetic Alopecia in the Female

research Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women

research Topical Minoxidil in Male Pattern Baldness: Effects of Discontinuation of Treatment

research Long-Term Follow-Up of Men with Male Pattern Baldness Treated with Topical Minoxidil

research Topical Minoxidil (3%) in Extensive Alopecia Areata, Including Long-Term Efficacy

research Topical Minoxidil in Early Male Pattern Baldness